Alibaba Group Holding Ltd: Form 20-F for the period ended Mar 31, 2022
Filed with the SEC on Jul 26, 2022 and accepted by EDGAR at Jul 26, 2022, 07:49 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-04-01 to 2022-03-31 | $134.57bn | us-gaap:Revenues |
| Cost of revenue | 12 months2021-04-01 to 2022-03-31 | $85.10bn | us-gaap:CostOfRevenue |
| Research and development | 12 months2021-04-01 to 2022-03-31 | $8.75bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2021-04-01 to 2022-03-31 | $10.98bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-04-01 to 2022-03-31 | $774.0m | us-gaap:InterestExpense |
| Income tax | 12 months2021-04-01 to 2022-03-31 | $4.23bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-04-01 to 2022-03-31 | $9.82bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-04-01 to 2022-03-31 | $0.45 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-04-01 to 2022-03-31 | $0.45 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-04-01 to 2022-03-31 | 21,787,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-04-01 to 2022-03-31 | $22.52bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 12 months2021-04-01 to 2022-03-31 | $9.66bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-03-31 | $29.96bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-03-31 | $100.73bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $267.47bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $60.54bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $96.75bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-03-31 | $149.62bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-03-31 | 21,357,323,112 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-22-082622. Last ingested by Listed: Nov 5, 2026, 11:20 ET. Listed shows no prices and gives no investment advice.